OBJECTIVE
The authors examined the developmental impact and temporal characteristics of risperidone-associated weight change.
METHOD
Weight change was measured for 63 children and adolescents with autism treated with risperidone for 6 months. Change in serum leptin levels after 2 months was examined as a predictor of final weight gain in mixed regression models that controlled for site, gende...
